Vironexis Biotherapeutics Inc.
2 clinical trials · Sponsor
◉ Watch Vironexis Biotherapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Gene Therapy for HER-Positive Cancer (SENTRY-HER2) (NCT07192432) | Vironexis Biotherapeutics Inc. | 2025-11-18 |
| Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) (NCT06533579) | Vironexis Biotherapeutics Inc. | 2025-05-30 |
Track Vironexis Biotherapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.